WHO ICTRP trial
Prospective clinical research of radiofrequency catheter septal ablation for…
ChiCTR2000028976 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000028976 |
|---|---|
| Public title | Prospective clinical research of radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy |
| Scientific title | Prospective clinical research of radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy |
| Primary sponsor | Xiamen University Affiliated Cardiovascular Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | hypertrophic obstructive cardiomyopathy |
| Interventions | Ablation group:endocardial radiofrequency ablation of septal hypertrophy |
| Registration date | Jan 10, 2020 |
| Target size | Ablation group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: